Acquisition Develop Incubator San Diego 
socalTECH
FEBRUARY 20, 2019
San Diego-based Portfolium , a startup developing tools to allow students to showcase their achievements, projects, and other portfolio of academic work to potential employers, has been acquired by educational software provider Instructure , the two announced late Tuesday. Financial details of the acquisition were not announced.
socalTECH
JULY 19, 2019
San Diego-based medical technology startup CARLSMED has merged with Seattle-based Precisive Surgical , the two said this week, to combine their efforts to develop a personalized surgical workflow platform for spine deformity intervention. Financial terms of the acquisition were not announced. READ MORE>>.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch LA
MARCH 22, 2018
The Alliance estimates that Southern California’s tech community could be one-third the size of Silicon Valley’s by supporting or further developing the six pillars it already has for innovation to occur.
socalTECH
DECEMBER 11, 2014
San Diego-based RapidEngage , a developer of online survey software and tools used to collect customer feedback and to engage users, has been acquired by fellow online survey company QuestionPro. RapidEngage was one of the companies incubated at EvoNexus. Financial terms of the buy were not disclosed. READ MORE>>.
socalTECH
NOVEMBER 13, 2019
San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.
socalTECH
APRIL 10, 2013
San Diego-based Xpenser , a startup developing a cloud-based service to help prepare and submit expense reports for its users, has been acquired. The firm was one of the companies which had been part of the EvoNexus incubator. xpenser expense management software travel tande coupa merger acquisition evonexus'
socalTECH
SEPTEMBER 11, 2019
San Diego-based biotech investor Avalon Ventures has scored an exit, saying late Tuesday evening that it has entered into a definitive agreement with GlaxoSmithKline (GSK), to sell Sitari Pharmaceuticals to GSK. Sitari was developing treatments for celiac disease, and was being incubated at COI Pharmaceuticals.
Expert insights. Personalized for you.
172 
Let's personalize your content